IE791023L - Unsaturated fatty acid and derivatives for use in thrombo-¹embolic disease - Google Patents

Unsaturated fatty acid and derivatives for use in thrombo-¹embolic disease

Info

Publication number
IE791023L
IE791023L IE791023A IE102379A IE791023L IE 791023 L IE791023 L IE 791023L IE 791023 A IE791023 A IE 791023A IE 102379 A IE102379 A IE 102379A IE 791023 L IE791023 L IE 791023L
Authority
IE
Ireland
Prior art keywords
pharmaceutically acceptable
1embolic
thrombo
disease
derivatives
Prior art date
Application number
IE791023A
Other versions
IE48287B1 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IE791023L publication Critical patent/IE791023L/en
Publication of IE48287B1 publication Critical patent/IE48287B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A pharmaceutical composition contains (all-Z)-5,8,11,14,17-eicosapentaenoic acid or one of its pharmaceutically acceptable salts, esters or amides and a pharmaceutically acceptable vehicle. The (all-Z)-5,8,11,14,17-eicosapentaenoic acid or its pharmaceutically acceptable salts, esters or amides can be used for the treatment or prophylaxis of thromboembolic states, to increase the bleeding time, dissolve or disperse thrombi or platelet aggregates which have already formed or to modify or prevent the adhesion of platelets to damaged tissue. They can furthermore be used to treat platelets in order to reduce their tendency to aggregation and/or to increase the rate of their separation from one another. They can furthermore be used as additive to blood in an extracorporeal circulation. [FR2426461A1]
IE1023/79A 1978-05-26 1979-08-08 Fatty acid and derivatives thereof for use in treatment of prophylaxis of thrombo-embolic conditions IE48287B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations
GB2357478 1978-05-26

Publications (2)

Publication Number Publication Date
IE791023L true IE791023L (en) 1979-11-26
IE48287B1 IE48287B1 (en) 1984-11-28

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1023/79A IE48287B1 (en) 1978-05-26 1979-08-08 Fatty acid and derivatives thereof for use in treatment of prophylaxis of thrombo-embolic conditions

Country Status (13)

Country Link
JP (1) JPS5515444A (en)
AU (1) AU527784B2 (en)
CA (1) CA1151068A (en)
CH (1) CH644267A5 (en)
DE (1) DE2831507A1 (en)
ES (1) ES8104983A1 (en)
FR (1) FR2426461A1 (en)
IE (1) IE48287B1 (en)
IL (1) IL55227A (en)
IT (1) IT1116505B (en)
NL (1) NL191332C (en)
NZ (1) NZ187908A (en)
SE (1) SE448678B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS59172416A (en) * 1983-03-18 1984-09-29 Terumo Corp Fat transfusion solution
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (en) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The Food or drug for preventing thrombosis
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (en) * 1984-08-29 1995-05-31 日本油脂株式会社 Tube feeding composition
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
NL9401743A (en) * 1994-10-20 1996-06-03 Prospa Bv Salts of amino alcohols and pharmaceutical formulations containing them.
DE19503993A1 (en) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Enteral product contg n-3-fatty acid or deriv and medium chain length tri:glyceride
DE10056351A1 (en) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmaceutical preparation containing omega-3 fatty acids and other active substances e.g. an antiinflammatory, cyclooxygenase II inhibitor, 5-lipoxygenase inhibitor or platelet aggregation inhibitor
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
EP2424521A4 (en) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
BRPI1011876B1 (en) 2009-04-29 2020-03-31 Amarin Pharma, Inc. STABLE PHARMACEUTICAL COMPOSITIONS UNDERSTANDING EICOSAPENTAENOIC ETHYLACID (ETHYL-EPA) AND USE OF THE SAME TO TREAT OR PREVENT A CARDIOVASCULAR DISEASE
DK2443246T3 (en) 2009-06-15 2018-03-26 Amarin Pharmaceuticals Ie Ltd COMPOSITIONS AND METHODS FOR REDUCING TRIGLYCERIDES WITHOUT INCREASING LDL-C LEVELS IN AN INDIVIDUAL WITH CURRENT STATE THERAPY
RU2012116079A (en) 2009-09-23 2013-10-27 АМАРИН КОРПОРЕЙШН ПиЭлСи PHARMACEUTICAL COMPOSITION, INCLUDING OMEGA-3 FATTY ACID AND HYDROXY DERIVATED STATIN AND WAYS OF ITS APPLICATION
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
AU2013207368A1 (en) 2012-01-06 2014-07-24 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-CRP) in a subject
EP4342546A3 (en) 2012-06-29 2024-05-22 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
KR20150115745A (en) 2013-02-06 2015-10-14 에이전시 포 사이언스, 테크놀로지 앤드 리서치 Methods for reducing aggregate content in protein preparations
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
TW201900160A (en) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 Compositions and Methods for Lowering Triglycerides in a Subject Having Reduced Kidney Function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
KR20210110890A (en) 2018-09-24 2021-09-09 애머린 파마슈티칼스 아일랜드 리미티드 Methods of reducing the risk of cardiovascular events in a subject

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE319677B (en) * 1965-03-27 1970-01-19 Sumitomo Chemical Co
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
JPS6257605A (en) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi Method for extracting effective component from multiple-element mineral

Also Published As

Publication number Publication date
SE448678B (en) 1987-03-16
FR2426461B1 (en) 1983-02-11
ES480921A0 (en) 1981-05-16
CA1151068A (en) 1983-08-02
IE48287B1 (en) 1984-11-28
FR2426461A1 (en) 1979-12-21
NZ187908A (en) 1984-05-31
CH644267A5 (en) 1984-07-31
JPS5515444A (en) 1980-02-02
IL55227A (en) 1982-12-31
AU3808478A (en) 1980-01-17
NL191332B (en) 1995-01-02
DE2831507C2 (en) 1989-07-13
NL191332C (en) 1995-06-01
IT7947717A0 (en) 1979-01-19
NL7904144A (en) 1979-11-28
DE2831507A1 (en) 1979-11-29
SE7904570L (en) 1979-11-27
AU527784B2 (en) 1983-03-24
IT1116505B (en) 1986-02-10
ES8104983A1 (en) 1981-05-16
IL55227A0 (en) 1978-09-29

Similar Documents

Publication Publication Date Title
IE791023L (en) Unsaturated fatty acid and derivatives for use in thrombo-¹embolic disease
GB2221843B (en) Fatty acid composition
PT64840A (en) PROCESS FOR THE PREPARATION OF ARALQUILIC ESTERS OF 1,4-DIHYDRAPIRIDINOCARBOXILIC ACID WITH CORONARY AND ANTIHYPERTENSIVE EFFECT APPLICATION OF THE SAME FOR THE PREPARATION OF CORONARY AND ANTIHYPERTENSIVE PHARMACEUTICAL COMPOSITIONS AND APPLICATION OF SAID PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BLOOD LACIRCULATION DISEASES
GB229644A (en) A method of producing a substance adapted to tampon wounds
HK37694A (en) Fatty acids compositions
DE3371866D1 (en) Medicine, mixed calcium salts of polymeric anionic carboxylic acids and/or their sulfuric acid esters, process for their preparation and their use
SE8901041D0 (en) ANTITROMOBOTIC PHARMACEUTICAL PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION
IE45439L (en) Penicillanic acid derivatives
PT79648B (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH SPECIAL 1,2-DIACYL-GLYCERO-3-PHOSPHOCHOLINES FOR THE TREATMENT OF DISEASES IN THE STOMACH-DARM AREA
DE3937607A1 (en) USE OF AN ANTI-COAGULAR TREATMENT FOR TUMOR DISEASES
JPS6434909A (en) Cosmetic
DK0594770T3 (en) Ophthalmological mixtures
EP0302481A3 (en) Use of free fatty acids for the manufacture of a medicament for treatment of diabetes mellitus
ATE142491T1 (en) AGENTS FOR THE TREATMENT OF ATOPIC ECZEMA AND OTHER INFLAMMATORY SKIN DISEASES
DE69207885T2 (en) Gammalinolenic acid for the manufacture of a medicament for preventing artery reclosure
IE44030L (en) Ó-amino-ketones.
IE39239B1 (en) Cycloalkyl alkyl esters and process for their preparation
EP0300960A3 (en) Pharmaceutical compositions and lactosyl compounds, and their preparation
ES8200363A1 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them.
GR3001209T3 (en) 4-methoxy-isophthalic acid derivative having a pharmacological activity in thromboembolic disorders and a process for the preparation thereof
JPS55120560A (en) Acylated indole derivative, its preparation, and blood platelet aggregation inhibitor comprising it as active constituent
Finucane et al. Double-blind comparison of lidocaine and etidocaine during continuous epidural anesthesia for vaginal delivery
AT298444B (en) Process for the preparation of the new 4-aminomethylbicyclo [2,2,1] heptane-1-carboxylic acid and its salts, esters and N-alkanoyl derivatives
JPS55120561A (en) Acylated indole derivative, its preparation, and blood platelet aggregation inhibitor comprising it as active constituent
IE780207L (en) 4-hydroxy-1,2-benzisothiazole

Legal Events

Date Code Title Description
MK9A Patent expired